Pittenger & Anderson Inc Actinium Pharmaceuticals, Inc. Transaction History
Pittenger & Anderson Inc
- $2.54 Billion
- Q2 2025
A detailed history of Pittenger & Anderson Inc transactions in Actinium Pharmaceuticals, Inc. stock. As of the latest transaction made, Pittenger & Anderson Inc holds 341 shares of ATNM stock, worth $477. This represents 0.0% of its overall portfolio holdings.
Number of Shares
341
Previous 341
-0.0%
Holding current value
$477
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ATNM
# of Institutions
62Shares Held
6.91MCall Options Held
39.2KPut Options Held
0-
Black Rock Inc. New York, NY1.88MShares$2.63 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.37MShares$1.92 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny663KShares$928,5760.0% of portfolio
-
Acadian Asset Management LLC Boston, MA492KShares$688,7200.0% of portfolio
-
Geode Capital Management, LLC Boston, MA330KShares$461,5640.0% of portfolio
About Actinium Pharmaceuticals, Inc.
- Ticker ATNM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,184,700
- Market Cap $35.3M
- Description
- Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...